Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat alopecia areata in children.

The review says skin conditions with sterile pustules need more research for better treatments.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Adalimumab helped control a child's severe eye disease when other treatments failed.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Some cancer treatments can cause permanent hair loss.

Minoxidil slows down keratinocyte growth without being toxic.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Low-dose oral minoxidil is an effective and well-tolerated treatment for hair growth in alopecia patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.